125 related articles for article (PubMed ID: 38544375)
1. Variant-specific in vitro neuronal network phenotypes and drug sensitivity in SCN2A developmental and epileptic encephalopathy.
Jia L; Li M; Pachernegg S; Sedo A; Jancovski N; Burbano LE; Dalby K; Nemiroff A; Reid C; Maljevic S; Petrou S
J Neurochem; 2024 Mar; ():. PubMed ID: 38544375
[TBL] [Abstract][Full Text] [Related]
2. Distinctive In Vitro Phenotypes in iPSC-Derived Neurons From Patients With Gain- and Loss-of-Function
Mao M; Mattei C; Rollo B; Byars S; Cuddy C; Berecki G; Heighway J; Pachernegg S; Menheniott T; Apted D; Jia L; Dalby K; Nemiroff A; Mullen S; Reid CA; Maljevic S; Petrou S
J Neurosci; 2024 Feb; 44(8):. PubMed ID: 38148154
[No Abstract] [Full Text] [Related]
3. Dynamic action potential clamp predicts functional separation in mild familial and severe de novo forms of
Berecki G; Howell KB; Deerasooriya YH; Cilio MR; Oliva MK; Kaplan D; Scheffer IE; Berkovic SF; Petrou S
Proc Natl Acad Sci U S A; 2018 Jun; 115(24):E5516-E5525. PubMed ID: 29844171
[TBL] [Abstract][Full Text] [Related]
4. Differential Functional Changes of Nav1.2 Channel Causing
Miao P; Tang S; Ye J; Tang J; Wang J; Zheng C; Li Y; Feng J
Front Neurol; 2021; 12():653517. PubMed ID: 34093402
[No Abstract] [Full Text] [Related]
5. Electrophysiological features: The next precise step for SCN2A developmental epileptic encephalopathy.
Miao P; Tang S; Ye J; Wang J; Lou Y; Zhang B; Xu X; Chen X; Li Y; Feng J
Mol Genet Genomic Med; 2020 Jul; 8(7):e1250. PubMed ID: 32400968
[TBL] [Abstract][Full Text] [Related]
6. Hyperexcitability and Pharmacological Responsiveness of Cortical Neurons Derived from Human iPSCs Carrying Epilepsy-Associated Sodium Channel Nav1.2-L1342P Genetic Variant.
Que Z; Olivero-Acosta MI; Zhang J; Eaton M; Tukker AM; Chen X; Wu J; Xie J; Xiao T; Wettschurack K; Yunis L; Shafer JM; Schaber JA; Rochet JC; Bowman AB; Yuan C; Huang Z; Hu CD; Trader DJ; Skarnes WC; Yang Y
J Neurosci; 2021 Dec; 41(49):10194-10208. PubMed ID: 34716231
[TBL] [Abstract][Full Text] [Related]
7. A SCN8A variant associated with severe early onset epilepsy and developmental delay: Loss- or gain-of-function?
Liu Y; Koko M; Lerche H
Epilepsy Res; 2021 Dec; 178():106824. PubMed ID: 34847423
[TBL] [Abstract][Full Text] [Related]
8. Distinguishing Loss-of-Function and Gain-of-Function
Hack JB; Horning K; Juroske Short DM; Schreiber JM; Watkins JC; Hammer MF
Neurol Genet; 2023 Jun; 9(3):e200060. PubMed ID: 37152443
[TBL] [Abstract][Full Text] [Related]
9. Generation of an iPSC line (FINi001-A) from a girl with developmental and epileptic encephalopathy due to a heterozygous gain-of-function p.R1882Q variant in the voltage-gated sodium channel Na
Ovchinnikov DA; Jong S; Cuddy C; Scheffer IE; Maljevic S; Petrou S
Stem Cell Res; 2023 Sep; 71():103179. PubMed ID: 37597357
[TBL] [Abstract][Full Text] [Related]
10. Functional correlates of clinical phenotype and severity in recurrent SCN2A variants.
Berecki G; Howell KB; Heighway J; Olivier N; Rodda J; Overmars I; Vlaskamp DRM; Ware TL; Ardern-Holmes S; Lesca G; Alber M; Veggiotti P; Scheffer IE; Berkovic SF; Wolff M; Petrou S
Commun Biol; 2022 May; 5(1):515. PubMed ID: 35637276
[TBL] [Abstract][Full Text] [Related]
11. Further corroboration of distinct functional features in SCN2A variants causing intellectual disability or epileptic phenotypes.
Begemann A; Acuña MA; Zweier M; Vincent M; Steindl K; Bachmann-Gagescu R; Hackenberg A; Abela L; Plecko B; Kroell-Seger J; Baumer A; Yamakawa K; Inoue Y; Asadollahi R; Sticht H; Zeilhofer HU; Rauch A
Mol Med; 2019 Feb; 25(1):6. PubMed ID: 30813884
[TBL] [Abstract][Full Text] [Related]
12. Expanded clinical phenotype spectrum correlates with variant function in SCN2A-related disorders.
Berg AT; Thompson CH; Myers LS; Anderson E; Evans L; Kaiser AJE; Paltell K; Nili AN; DeKeyser JM; Abramova TV; Nesbitt G; Egan S; Vanoye CG; George AL
Brain; 2024 Apr; ():. PubMed ID: 38651838
[TBL] [Abstract][Full Text] [Related]
13. Alternative splicing potentiates dysfunction of early-onset epileptic encephalopathy SCN2A variants.
Thompson CH; Ben-Shalom R; Bender KJ; George AL
J Gen Physiol; 2020 Mar; 152(3):. PubMed ID: 31995133
[TBL] [Abstract][Full Text] [Related]
14. Biophysical characterization and modelling of SCN1A gain-of-function predicts interneuron hyperexcitability and a predisposition to network instability through homeostatic plasticity.
Berecki G; Bryson A; Polster T; Petrou S
Neurobiol Dis; 2023 Apr; 179():106059. PubMed ID: 36868483
[TBL] [Abstract][Full Text] [Related]
15. Enhanced slow inactivation contributes to dysfunction of a recurrent SCN2A mutation associated with developmental and epileptic encephalopathy.
Ganguly S; Thompson CH; George AL
J Physiol; 2021 Sep; 599(18):4375-4388. PubMed ID: 34287911
[TBL] [Abstract][Full Text] [Related]
16. Resurgent and Gating Pore Currents Induced by
Mason ER; Wu F; Patel RR; Xiao Y; Cannon SC; Cummins TR
eNeuro; 2019; 6(5):. PubMed ID: 31558572
[TBL] [Abstract][Full Text] [Related]
17. Excitatory and inhibitory neuron defects in a mouse model of Scn1b-linked EIEE52.
Hull JM; O'Malley HA; Chen C; Yuan Y; Denomme N; Bouza AA; Anumonwo C; Lopez-Santiago LF; Isom LL
Ann Clin Transl Neurol; 2020 Nov; 7(11):2137-2149. PubMed ID: 32979291
[TBL] [Abstract][Full Text] [Related]
18. Pathogenic SCN2A variants cause early-stage dysfunction in patient-derived neurons.
Asadollahi R; Delvendahl I; Muff R; Tan G; Rodríguez DG; Turan S; Russo M; Oneda B; Joset P; Boonsawat P; Masood R; Mocera M; Ivanovski I; Baumer A; Bachmann-Gagescu R; Schlapbach R; Rehrauer H; Steindl K; Begemann A; Reis A; Winkler J; Winner B; Müller M; Rauch A
Hum Mol Genet; 2023 Jun; 32(13):2192-2204. PubMed ID: 37010102
[TBL] [Abstract][Full Text] [Related]
19. Human
Wei AD; Wakenight P; Zwingman TA; Bard AM; Sahai N; Willemsen MH; Schelhaas HJ; Stegmann APA; Verhoeven JS; de Man SA; Wessels MW; Kleefstra T; Shinde DN; Helbig KL; Basinger A; Wagner VF; Rodriguez-Buritica D; Bryant E; Millichap JJ; Millen KJ; Dobyns WB; Ramirez JM; Kalume FK
J Neurophysiol; 2022 Jul; 128(1):40-61. PubMed ID: 35583973
[TBL] [Abstract][Full Text] [Related]
20. Distinct epilepsy phenotypes and response to drugs in KCNA1 gain- and loss-of function variants.
Miceli F; Guerrini R; Nappi M; Soldovieri MV; Cellini E; Gurnett CA; Parmeggiani L; Mei D; Taglialatela M
Epilepsia; 2022 Jan; 63(1):e7-e14. PubMed ID: 34778950
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
